Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man

Acta Endocrinol (Copenh). 1990 Dec;123(6):591-7.

Abstract

To study the influence of the pancreatic neuropeptides, galanin and calcitonin gene-related peptide, on insulin and glucagon secretion in man, synthetic porcine galanin (80 pmol.kg-1.min-1; N = 6) or synthetic human calcitonin gen-related peptide (10 pmol.kg-1.min-1; N = 5) was infused intravenously in human volunteers. Following 5 min of infusion, arginine (5 g bolus + 10 mg.kg-1.min-1) was given. Galanin did not affect basal or arginine-stimulated insulin secretion judged from determinations of plasma insulin and C-peptide. Similarly, galanin did not affect arginine-stimulated glucagon secretion. Calcitonin gene-related peptide did not affect basal or arginine-stimulated insulin or glucagon secretion. However, calcitonin gene-related peptide slightly potentiated the arginine-induced hyperglycemia (p less than 0.01). Thus, in man, galanin has no influence on insulin or glucagon secretion when infused at 80 pmol.kg-1.min-1, whereas CGRP at 10 pmol.kg-1.min-1 induces slight hyperglycemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arginine / pharmacology
  • Blood Glucose / metabolism
  • C-Peptide / blood
  • Calcitonin Gene-Related Peptide / administration & dosage
  • Calcitonin Gene-Related Peptide / pharmacology*
  • Drug Synergism
  • Female
  • Galanin
  • Glucagon / metabolism*
  • Humans
  • Insulin / metabolism*
  • Insulin Secretion
  • Kinetics
  • Male
  • Peptides / administration & dosage
  • Peptides / pharmacology*

Substances

  • Blood Glucose
  • C-Peptide
  • Insulin
  • Peptides
  • Galanin
  • Glucagon
  • Arginine
  • Calcitonin Gene-Related Peptide